Ewa Zoltek-Rescigno Dmd is categorized under Doctors in Englewood Cliffs, NJ and active since 2010.
Ewa Zoltek-Rescigno Dmd was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ewa Zoltek-Rescigno at the company’s single location by writing to 44 Sylvan Avenue # 1d, Englewood Cliffs, New Jersey NJ 07632 or by phoning (201) 592-9300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ewa Zoltek-Rescigno Dmd |
| Contact Person: | Ewa Zoltek-Rescigno |
| Address: | 44 Sylvan Avenue # 1d, Englewood Cliffs, New Jersey 07632 |
| Phone Number: | (201) 592-9300 |
| Website Address: | doctorezr.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Ewa Zoltek-Rescigno Dmd was started in 2010 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ewa Zoltek-Rescigno for inquiries that concern Ewa Zoltek-Rescigno Dmd by calling the company number (201) 592-9300, as your correspondence is most welcome. Additionally, the physical location of the single location of Ewa Zoltek-Rescigno Dmd can be found at the coordinates 40.867832,-73.958773 as well as the street address 44 Sylvan Avenue # 1d in Englewood Cliffs, New Jersey 07632.
For its online presence, you may visit Ewa Zoltek-Rescigno Dmd’s website at doctorezr.com and engage with its social media outlets through on Twitter and on Facebook.